Response to comments on "Reproductive toxicology studies supporting the safety of molindone, a dopamine receptor antagonist"
Birth Defects Res
.
2019 Mar 1;111(4):230-231.
doi: 10.1002/bdr2.1447.
Epub 2019 Jan 11.
Authors
Gopakumar Gopalakrishnan
1
,
Shivaputhrappa Ganiger
2
,
Tacey E K White
3
,
Chungping Yu
4
Affiliations
1
Preclinical Toxicology, Supernus Pharmaceuticals, Inc., Rockville, Maryland.
2
Eurofins Advinus Ltd., Bengaluru, Karnataka, India.
3
DART and Juvenile Toxicology, Aclairo Pharmaceutical Development Group, Inc., Vienna, Virginia.
4
Preclinical DMPK and Pharmacology, Supernus Pharmaceuticals, Inc., Rockville, Maryland.
PMID:
30632696
DOI:
10.1002/bdr2.1447
No abstract available
Publication types
Letter
Comment
MeSH terms
Dopamine Antagonists*
Molindone*
Reproduction
Substances
Dopamine Antagonists
Molindone